The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dieli, F.
Right arrow Articles by Salerno, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dieli, F.
Right arrow Articles by Salerno, A.

The Journal of Immunology, Vol 152, Issue 6 2698-2704, Copyright © 1994 by American Association of Immunologists


ARTICLES

IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of gamma/delta cells

F Dieli, GL Asherson, GC Romano, G Sireci, F Gervasi and A Salerno
Institute of General Pathology, University of Palermo, Italy.

Hapten (trinitrophenyl)-specific T cell lines were obtained by repeated stimulation of lymph node cells from immune mice with Ag in vitro. These T cell lines show phenotypic properties and a pattern of cytokine production typical of Th1 cells and consisted of more than 90% V beta 8.2+ T lymphocytes and 6 to 9% gamma/delta + T lymphocytes. The lines mediate a local passive transfer of DTH when injected at the site of Ag challenge but fail to mediate a systemic passive transfer of DTH when injected i.v. However, a successful systemic passive transfer of DTH was observed when IL-4 was given to recipient mice together with the T cell lines or when the T cell lines were incubated in vitro with IL-4. IL-4 enables systemic, specific passive transfer of DTH at a dose of 10 pg/ml in vitro and at a dose of 10 pg/mouse in vivo; it is effective when injected 4 h before cell transfer but not when given 1 to 5 days earlier. Cytofluorimetric analysis shows that the gamma/delta + cells and not the V beta 8.2+ cells of the line express IL-4R and a good systemic transfer of DTH is observed when gamma/delta + cells are incubated in vitro with IL-4 and then injected together with V beta 8.2+ cells into recipient mice. In contrast, injection of V beta 8.2+ cells treated with IL-4 together with gamma/delta + cells fails to transfer DTH. Overall, the present results show that IL-4 is an important mediator in the DTH reaction and that gamma/delta + cells are one of the targets of its action.


This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Blackstock and J. W. Murphy
Role of Interleukin-4 in Resistance to Cryptococcus neoformans Infection
Am. J. Respir. Cell Mol. Biol., January 1, 2004; 30(1): 109 - 117.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. R. Drobyski, S. Vodanovic-Jankovic, and J. Klein
Adoptively Transferred {gamma}{delta} T Cells Indirectly Regulate Murine Graft-Versus-Host Reactivity Following Donor Leukocyte Infusion Therapy in Mice
J. Immunol., August 1, 2000; 165(3): 1634 - 1640.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Yokozeki, M. Ghoreishi, S. Takagawa, K. Takayama, T. Satoh, I. Katayama, K. Takeda, S. Akira, and K. Nishioka
Signal Transducer and Activator of Transcription 6 Is Essential in the Induction of Contact Hypersensitivity
J. Exp. Med., March 20, 2000; 191(6): 995 - 1004.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Kitagaki, M. Kimishima, Y. Teraki, J. Hayakawa, K. Hayakawa, S. Fujisawa, and T. Shiohara
Distinct In Vivo and In Vitro Cytokine Profiles of Draining Lymph Node Cells in Acute and Chronic Phases of Contact Hypersensitivity: Importance of a Type 2 Cytokine-Rich Cutaneous Milieu for the Development of an Early-Type Response in the Chronic Phase
J. Immunol., August 1, 1999; 163(3): 1265 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. S. Kim, W. Maslinski, X. X. Zheng, A. C. Stevens, X. C. Li, G. H. Tesch, V. R. Kelley, and T. B. Strom
Targeting the IL-15 Receptor with an Antagonist IL-15 Mutant/Fc{gamma}2a Protein Blocks Delayed-Type Hypersensitivity
J. Immunol., June 15, 1998; 160(12): 5742 - 5748.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.